HNWAG
WVE icon

High Net Worth Advisory Group’s Wave Life Sciences WVE Stock Holding History

High Net Worth Advisory Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$3K – 730
2022
Q2 		$3K Buy
+1,000
New +$1.92K ﹤0.01% 619

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

High Net Worth Advisory Group's WVE Position: Q3 2022 in Review

High Net Worth Advisory Group sold out of Wave Life Sciences (WVE) in Q3 2022, closing a stake of 1,000 shares — an estimated $3K sold.

High Net Worth Advisory Group first reported a position in WVE in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 61 funds tracked by Wall St. Rank hold WVE as of Q3 2022.

  • High Net Worth Advisory Group reported no remaining Wave Life Sciences position as of Q3 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 1,000 Wave Life Sciences shares in Q3 2022, an estimated $3K.
  • High Net Worth Advisory Group first reported a position in Wave Life Sciences in Q2 2022 and held it in 1 quarter.
  • High Net Worth Advisory Group's Wave Life Sciences position peaked at $3K in Q2 2022.
  • 61 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2022.

Based on High Net Worth Advisory Group's 13F filing for Q3 2022, filed 24 Oct 2022.